Ligand profile
ZINC169748244
Virtual-screening candidate from ZINC.
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC169748244- UniProt (similar protein)
Q93LQ9- Tanimoto
- 1.000
- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 62.5
- −1 ≤ LogP ≤ 5 1.57
- MW ≤ 500 Da 251.0
- LogP ≤ 5 1.57
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 62.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1
InChI=1S/C14H10BNO3/c16-8-10-1-3-12(4-2-10)19-13-5-6-14-11(7-13)9-18-15(14)17/h1-7,17H,9H2InChI=1S/C14H10BNO3/c16-8-10-1-3-12(4-2-10)19-13-5-6-14-11(7-13)9-18-15(14)17/h1-7,17H,9H2
USZAGAREISWJDP-UHFFFAOYSA-NUSZAGAREISWJDP-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL484785
- Homolog
- Q93LQ9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC169748244 →
- ZINC ZINC20 ZINC169748244 →
- UniProt UniProt Q93LQ9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC169748244”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 36
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).